BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,080 filers reported holding BAXTER INTL INC in Q3 2020. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
About BAXTER INTL INC
Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.
Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.
Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.
Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.
Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $19,610,000 | -8.9% | 227,765 | -14.1% | 0.18% | -7.7% |
| Q1 2020 | $21,525,000 | -54.1% | 265,128 | -52.7% | 0.19% | -30.0% |
| Q4 2019 | $46,899,000 | +14.9% | 560,865 | +20.2% | 0.28% | +16.9% |
| Q3 2019 | $40,815,000 | +38.4% | 466,632 | +29.6% | 0.24% | +54.9% |
| Q2 2019 | $29,486,000 | -19.3% | 360,028 | -19.9% | 0.15% | -19.0% |
| Q1 2019 | $36,533,000 | -72.0% | 449,309 | -77.4% | 0.19% | -74.2% |
| Q4 2018 | $130,673,000 | -52.1% | 1,985,312 | -43.9% | 0.73% | -43.2% |
| Q3 2018 | $272,966,000 | -6.8% | 3,540,875 | -10.7% | 1.29% | -4.5% |
| Q2 2018 | $292,771,000 | +12.6% | 3,964,942 | -0.8% | 1.35% | +13.5% |
| Q1 2018 | $259,960,000 | -5.5% | 3,996,927 | -6.1% | 1.19% | +0.4% |
| Q4 2017 | $275,055,000 | -3.2% | 4,255,177 | -6.0% | 1.18% | -4.0% |
| Q3 2017 | $284,197,000 | -3.2% | 4,529,042 | -6.7% | 1.24% | -1.5% |
| Q2 2017 | $293,729,000 | +159.8% | 4,851,819 | +122.5% | 1.25% | +168.5% |
| Q1 2017 | $113,074,000 | +95.6% | 2,180,363 | +67.3% | 0.47% | +97.0% |
| Q4 2016 | $57,798,000 | +328.5% | 1,303,508 | +360.0% | 0.24% | +308.6% |
| Q3 2016 | $13,489,000 | +150.4% | 283,380 | +72.8% | 0.06% | +132.0% |
| Q3 2015 | $5,386,000 | -63.9% | 163,962 | -23.1% | 0.02% | -60.9% |
| Q2 2015 | $14,913,000 | +13.6% | 213,260 | +11.3% | 0.06% | +16.4% |
| Q1 2015 | $13,123,000 | -15.8% | 191,570 | -9.9% | 0.06% | -16.7% |
| Q4 2014 | $15,579,000 | +41.0% | 212,570 | +38.1% | 0.07% | +34.7% |
| Q3 2014 | $11,050,000 | – | 153,960 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Point | 36,000,000 | $2,658,240,000 | 18.52% |
| SECTOR GAMMA AS | 721,058 | $53,243,000 | 8.85% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 2,747,061 | $202,843,000 | 5.38% |
| Veritas Asset Management LLP | 8,852,005 | $653,632,000 | 5.36% |
| Knowledge Leaders Capital, LLC | 79,384 | $5,862,000 | 4.39% |
| HealthCor Management, L.P. | 1,800,000 | $132,912,000 | 4.22% |
| Progressive Investment Management Corp | 79,282 | $5,854,000 | 3.78% |
| 13D Management LLC | 200,318 | $14,791,000 | 3.77% |
| ARGENT CAPITAL MANAGEMENT LLC | 1,288,236 | $95,123,000 | 3.42% |
| Chiron Investment Management, LLC | 612,787 | $45,248,000 | 3.12% |